ClinicalTrials.gov
public full text
Public Domain
PRION-1: Quinacrine for Human Prion Disease
PRION-1 aims to assess the activity and safety of Quinacrine (Mepacrine hydrochloride) in human prion disease. It also aims to establish an appropriate framework for the clinical assessment of therapeutic options for human prion disease that can be refined or expanded in the future, as new agents become available.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prion diseases: Lessons from historical outbreaks and potential emerging ones.#223028
- Theory and simulations of delayed stochastic and deterministic models of prion diseases#235151
- theosanderson/hospitalmedicines#367702
- The evolution of duplicated genes of the Cpi-17/Phi-1 (ppp1r14) family of protein phosphatase 1 inhibitors in teleosts#453436
- New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies#1153522
Record · ID 880692
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive